Tag Archives: AstraZeneca

Analysts’ View: AstraZeneca (AZN), CBL & Associates Properties (CBL), Post Properties (PPS)

Brokerage Firm Argus upgraded AstraZeneca PLC (NYSE:AZN) shares from Hold to Buy rating.

AstraZeneca PLC engages in the discovery, development, and commercialization of prescription medicines for the treatment of respiratory, inflammation, autoimmune, cardiovascular, metabolic, oncology, infection, neuroscience, and gastrointestinal diseases worldwide.


Investment Analysts at Jefferies upgraded CBL & Associates Properties Inc.(NYSE:CBL) shares from Hold to Buy rating.

CBL & Associates Properties, Inc. is a public real estate investment trust. It engages in acquisition, development, and management of properties.


Post Properties Inc. (NYSE:PPS) shares were upgraded by analysts at Raymond James from Market Perform to Outperform.

Post Properties, Inc. is an independent real estate investment trust. The firm invests in the real estate markets of the United States.


Disclaimer: The disclaimer is to be read and fully understood before using our site, or joining our email list. CRWE.Info is not a registered investment adviser. This material is for informational purposes only and should not be construed as an offer or solicitation of an offer to buy or sell securities. Investors should always conduct their own due diligence with any potential investment, with independent research and other professional advice. Read full disclaimer at http://www.crwe.info/disclaimer/